ArticleFuture oncology (London, England)2025
Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK study.
Franco Antonio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it